Modeling the impact and costs of semiannual mass drug administration for accelerated elimination of lymphatic filariasis.
The Global Program to Eliminate Lymphatic Filariasis (LF) has a target date of 2020. This program is progressing well in many countries. However, progress has been slow in some countries, and others have not yet started their mass drug administration (MDA) programs. Acceleration is needed. We studie...
Saved in:
Main Authors: | Wilma A Stolk (Author), Quirine A ten Bosch (Author), Sake J de Vlas (Author), Peter U Fischer (Author), Gary J Weil (Author), Ann S Goldman (Author) |
---|---|
Format: | Book |
Published: |
Public Library of Science (PLoS),
2013-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Potential Value of Triple Drug Therapy with Ivermectin, Diethylcarbamazine, and Albendazole (IDA) to Accelerate Elimination of Lymphatic Filariasis and Onchocerciasis in Africa.
by: Peter U Fischer, et al.
Published: (2017) -
Quantifying the value of surveillance data for improving model predictions of lymphatic filariasis elimination.
by: Edwin Michael, et al.
Published: (2018) -
A review of factors that influence individual compliance with mass drug administration for elimination of lymphatic filariasis.
by: Alison Krentel, et al.
Published: (2013) -
The impact of four years of semiannual treatments with albendazole alone on lymphatic filariasis and soil-transmitted helminth infections: A community-based study in the Democratic Republic of the Congo.
by: Sébastien D S Pion, et al.
Published: (2020) -
Elimination of lymphatic filariasis in the Gambia.
by: Maria P Rebollo, et al.
Published: (2015)